Sanofi India Limited (BOM:500674)
3,306.10
+58.05 (1.79%)
At close: Jun 16, 2026
Sanofi India Market Cap
Sanofi India has a market cap or net worth of 76.14 billion as of June 16, 2026. Its market cap has decreased by -46.80% in one year.
Market Cap
76.14B
Enterprise Value
73.69B
Revenue
17.74B
Ranking
n/a
PE Ratio
24.58
Stock Price
3,306.10
Market Cap Chart
Since March 19, 2001, Sanofi India's market cap has increased from 11.29B to 76.14B, an increase of 574.71%. That is a compound annual growth rate of 7.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2026 | 76.14B | -19.20% |
| Dec 31, 2025 | 94.23B | -33.15% |
| Dec 31, 2024 | 140.97B | -24.12% |
| Dec 29, 2023 | 185.79B | 37.91% |
| Dec 30, 2022 | 134.72B | -25.89% |
| Dec 31, 2021 | 181.78B | -5.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Granules India | 185.61B |
| Caplin Point Laboratories | 180.74B |
| Jubilant Pharmova | 157.13B |
| Viyash Scientific | 107.89B |
| CORONA Remedies | 105.91B |
| Procter & Gamble Health | 103.53B |
| FDC Limited | 62.63B |
| Bliss GVS Pharma | 46.52B |